A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx.

MLA

Huang, Pei-Wei, et al. “A Phase II Randomized Trial Comparing Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone in Advanced Squamous Cell Carcinoma of the Pharynx or Larynx.” Biomedical Journal, vol. 41, no. 2, Apr. 2018, pp. 129–36. EBSCOhost, https://doi.org/10.1016/j.bj.2018.04.003.

APA

Huang, P.-W., Lin, C.-Y., Hsieh, C.-H., Hsu, C.-L., Fan, K.-H., Huang, S.-F., Liao, C.-T., Ng, S.-K., Yen, T.-C., Chang, J. T.-C., & Wang, H.-M. (2018). A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx. Biomedical Journal, 41(2), 129–136. https://doi.org/10.1016/j.bj.2018.04.003

Chicago

Huang, Pei-Wei, Chien-Yu Lin, Chia-Hsun Hsieh, Cheng-Lung Hsu, Kang-Hsing Fan, Shiang-Fu Huang, Chun-Ta Liao, et al. 2018. “A Phase II Randomized Trial Comparing Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone in Advanced Squamous Cell Carcinoma of the Pharynx or Larynx.” Biomedical Journal 41 (2): 129–36. doi:10.1016/j.bj.2018.04.003.